RecruitingNCT06550050

Clinical and Molecular Features of Oral Premalignancy and Oral Cancer

Clinical and Molecular Features of Oral Premalignancy and Oral Cancer Associated With Tumor Initiation, Aggressive Behavior, Treatment Response, and Survival Outcomes


Sponsor

M.D. Anderson Cancer Center

Enrollment

1,000 participants

Start Date

Oct 31, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Investigators will employ serial assessments of tissue biopsy and additional biomarkers that reflect burden of disease and predict treatment response. Patients enrolled on this study will be given the option to provide biological samples before, during, and after treatment, as well as functional outcomes of treatment response. These samples will be utilized to develop and validate prognostic and predictive biomarkers for patients undergoing targeted therapy, immunotherapy, surgery, chemotherapy, and/or radiotherapy.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting tissue samples, blood, and other biological materials from patients with oral premalignant conditions (like leukoplakia — white patches in the mouth) or oral cancer to better understand the molecular and genetic features that cause these conditions to develop or progress to cancer. This is a research registry and biobank study, not a treatment trial. **You may be eligible if...** - You are 18 years of age or older - You have been diagnosed with or are suspected to have an oral premalignant condition (such as leukoplakia, erythroplakia, or various degrees of dysplasia) or oral cancer - You are being evaluated at UT MD Anderson Cancer Center for the first time, OR you previously were treated there and have returned with progressive or recurrent disease - You are able to provide informed consent **You may NOT be eligible if...** - You are under 18 years old - You are unable to provide informed consent - You do not have a relevant oral premalignant or malignant diagnosis Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALRadiation

Standard of care


Locations(1)

MD Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06550050


Related Trials